Pharmacokinetics of Tranexamic Acid (TXA) in Children Undergoing Repair of Congenital Heart Defects Utilizing Cardiopulmonary Bypass
| Status: | Completed |
|---|---|
| Conditions: | Peripheral Vascular Disease, Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | Any - 21 |
| Updated: | 4/21/2016 |
| Start Date: | January 2010 |
| End Date: | December 2014 |
The purpose of this study is to measure blood levels of TXA in children having cardiac
surgery which requires cardiopulmonary bypass. TXA is used to reduce bleeding during
surgery. This study will help determine if the current dosing of TXA results in therapeutic
blood levels.
surgery which requires cardiopulmonary bypass. TXA is used to reduce bleeding during
surgery. This study will help determine if the current dosing of TXA results in therapeutic
blood levels.
Inclusion Criteria:
- congenital heart disease requiring surgical repair with cardiopulmonary bypass
Exclusion Criteria:
- children weighing over 20 kg
- family does not want to participate in the study
We found this trial at
1
site
Click here to add this to my saved trials
